Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学NET Pathology Classification, WHO

Guido Rindi

MD PhD

🏢Universita Cattolica del Sacro Cuore🌐Italy

Professor of Pathology

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Guido Rindi at Catholic University Rome has been central to developing WHO classifications of neuroendocrine neoplasms. His work on standardizing NET grading (G1/G2/G3 based on Ki67 index and mitotic rate), distinguishing well-differentiated neuroendocrine tumors from poorly differentiated neuroendocrine carcinomas (NECs), and his contributions to the WHO digestive and thoracic NET classification systems have been foundational for NET pathology standardization globally.

Share:

🧪Research Fields 研究领域

NET WHO classification
neuroendocrine tumor grading
Ki67 NET grading
NET pathology standards
NEC vs NET classification

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Guido Rindi 的研究动态

Follow Guido Rindi's research updates

留下邮箱,当我们发布与 Guido Rindi(Universita Cattolica del Sacro Cuore)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment